Other investigators for the project are Leon Thal, M.D., University of California at San Diego, (Coordinating Center), Ronald Petersen, M.D., Ph.D., of the Mayo Clinic, Rochester, MN (Clinical Aspects), Clifford Jack, M.D., Mayo Clinic (Neuroimaging/MRI Core); William Jagust, M.D., University of California, Berkeley (Neuroimaging/PET Core); John Q. Trojanowski, M.D., Ph.D., University of Pennsylvania (Biomarker Core); Arthur W. Toga, Ph.D., University of California, Los Angeles (Bioinformatics Core); and Laurel Beckett, Ph.D., University of California, Davis (Biostatistics Core). In addition, there are investigators at all of the study sites throughout the United States and Canada.

The public can find out more about participating in the research and obtain a list of study sites by contacting the NIA's Alzheimer's Disease Education and Referral (ADEAR) Center at 1-800-438-4380 or by visiting the ADNI section of the ADEAR website: www.alzheimers.org/imagine. Those interested in participating in the project are encouraged to contact the study site closest to them. Spanish-language capabilities are available at some of the study sites.


The NIA leads the Federal effort in research on AD and age-related cognitive change. For more information on participation in a number of clinical studies on AD, visit www.clinicaltrials.gov (search for "Alzheimer's disease" trials) or the ADEAR Center website at www.alzheimers.org, or contact ADEAR toll free at 1-800-438-4380.

The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary Federal agency for conducting and supporting basic, clinical, and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

Back to HCB News

More Industry Headlines